These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 17123289

  • 1. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia.
    Gores GJ, Gish RG, Sudan D, Rosen CB, MELD Exception Study Group.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S95-7. PubMed ID: 17123289
    [No Abstract] [Full Text] [Related]

  • 2. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.
    Freeman RB, Gish RG, Harper A, Davis GL, Vierling J, Lieblein L, Klintmalm G, Blazek J, Hunter R, Punch J.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S128-36. PubMed ID: 17123284
    [No Abstract] [Full Text] [Related]

  • 3. Orthotopic liver transplantation for biliary atresia complicated by incidental cholangiocarcinoma.
    Vera A, Villaveces D, López R.
    J Pediatr Gastroenterol Nutr; 2012 Sep; 55(3):336-7. PubMed ID: 21873891
    [No Abstract] [Full Text] [Related]

  • 4. Model for end-stage liver disease (MELD) exception for portal hypertensive gastrointestinal bleeding.
    Sheiner P, Gish RG, Sanyal A.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S112-3. PubMed ID: 17123290
    [No Abstract] [Full Text] [Related]

  • 5. Model for end-stage liver disease (MELD) exception guidelines.
    Wiesner R, Lake JR, Freeman RB, Gish RG.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S85-7. PubMed ID: 17123285
    [No Abstract] [Full Text] [Related]

  • 6. Model for end-stage liver disease (MELD) exception for polycystic liver disease.
    Arrazola L, Moonka D, Gish RG, Everson GT.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S110-1. PubMed ID: 17123287
    [No Abstract] [Full Text] [Related]

  • 7. Model for end-stage liver disease (MELD) exception for severe pruritus.
    Washburn WK, Gish RG.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S119. PubMed ID: 17123292
    [No Abstract] [Full Text] [Related]

  • 8. Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases.
    McDiarmid S, Gish RG, Horslen S, Mazariegos GV.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S124-7. PubMed ID: 17123278
    [No Abstract] [Full Text] [Related]

  • 9. Model for end-stage liver disease (MELD) exception for hepatic encephalopathy.
    Ham J, Gish RG, Mullen K.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S102-4. PubMed ID: 17123294
    [No Abstract] [Full Text] [Related]

  • 10. Model for end-stage liver disease (MELD) exception for cystic fibrosis.
    Horslen S, Sweet S, Gish RG, Shepherd R.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S98-9. PubMed ID: 17123272
    [No Abstract] [Full Text] [Related]

  • 11. Model for end-stage liver disease (MELD) exception for ascites.
    Biggins SW, Colquhoun S, Gish RG, Runyon BA.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S88-90. PubMed ID: 17123288
    [No Abstract] [Full Text] [Related]

  • 12. Model for end-stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia.
    Garcia-Tsao G, Gish RG, Punch J.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S108-9. PubMed ID: 17123286
    [No Abstract] [Full Text] [Related]

  • 13. Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome.
    Washburn WK, Gish RG, Kamath PS.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S93-4. PubMed ID: 17123293
    [No Abstract] [Full Text] [Related]

  • 14. Model for end-stage liver disease (MELD) exception for primary hyperoxaluria.
    Horslen S, Gish RG, McDonald R.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S117-8. PubMed ID: 17123291
    [No Abstract] [Full Text] [Related]

  • 15. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis.
    Varotti G, Gondolesi GE, Roayaie S, Suriawinata A, Soltys K, Fishbein TM, Schwartz ME, Miller C.
    J Am Coll Surg; 2003 Nov; 197(5):765-9. PubMed ID: 14585411
    [Abstract] [Full Text] [Related]

  • 16. Model for end-stage liver disease (MELD) exception for uncommon hepatic tumors.
    Punch J, Gish RG.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S122-3. PubMed ID: 17123279
    [No Abstract] [Full Text] [Related]

  • 17. Model for end-stage liver disease (MELD) exception small-for-size syndrome.
    Sheiner P, Belghiti J, Gish RG, Miller C.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S120-1. PubMed ID: 17123277
    [No Abstract] [Full Text] [Related]

  • 18. Model for end-stage liver disease (MELD) exception for bacterial cholangitis.
    Gores GJ, Gish RG, Shrestha R, Wiesner RH.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S91-2. PubMed ID: 17123280
    [No Abstract] [Full Text] [Related]

  • 19. Model for end-stage liver disease (MELD) exception for familial amyloidotic polyneuropathy.
    Pomfret E, Gish RG, Brandhagen D.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S100-1. PubMed ID: 17123281
    [No Abstract] [Full Text] [Related]

  • 20. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome.
    Fallon MB, Mulligan DC, Gish RG, Krowka MJ.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S105-7. PubMed ID: 17123282
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.